I am a Senior Trial Manager with over a decade of experience in clinical research. Formally a respiratory medicine scientist, I transitioned to clinical trials in 2014 when I joined the Nottingham Clinical Trials Unit (NCTU). Since then, I have overseen the delivery of multi-centre randomised trials across a broad range of therapeutic areas and serve as a co-investigator on several NIHR-funded studies. I have a strong interest in trial methodology and am an active member of several research networks, including the Trials Methodology Research Partnership, Trial Forge SWAT Network, and the Leicester and Partners RSS Methodology Hub. I also serve as Deputy Chair of the NCTU Research and Knowledge Exchange Committee

image here

Stephen Timmons is Professor of Health Services Management at Nottingham University Business School. His role within STARshiP is implementation research, that is, to study how to improve uptake of the STARshiP intervention by the NHS (assuming the study shows that the FMF screening test is effective). 

Eleanor Mitchell is an Associate Professor of Clinical Trials and a co-investigator on the STARSHIP trial. Her expertise is in the design and conduct of large, multicentre clinical trials in maternal and newborn health. She has led trials in the UK and low and middle income countries. She is particularly passionate about ensuring diverse patient and public involvement in trials and enjoys meeting parents to seek their input when designing trials. 

I am a Principal Research Fellow in Health Data Science, and after working for 10 years in Epidemiology and Public Health, I have joined the NCTU in November 2019 and worked in data-enabled trials since. I am currently leading the routine data flow and management for the GBS3 and STARship trial, two very large trials recruiting patients from several hospitals in England (and Wales for the GBS3). I am responsible for the data curation for these trials, including data collection from main national providers, data linkage, cleaning and processing. 

Marcus is his eighth year as CEO of the Action on Pre-eclampsia charity where he initially focussed on modernising the charity. Latterly he has worked on the continued international development of the charity, the focus on research where we’ve been involved in the publication of around 40 academic papers and on the external affairs and influencing role of APEC.

I am a Professor in Obstetrics at the University of Nottingham.  I divide my time equally between research and clinical work. My research work is based in Nottingham Clinical Trials Unit (NCTU). My clinical work is based at Nottingham University Hospitals Trust.

Clinically I have an interest in high-risk pregnancy, induction of labour and labour ward management.  My PhD focused on induction of labour and stillbirth.  My research work has focused on randomised controlled trials in obstetrics, sexual health and neonatology.  I am the Chief Investigator for the GBS3, GILD and DEBI trials.  I am a mum to two lovely teenagers who are rapidly growing taller than me!

Dr Liz Schroeder works in the health economics and policy evaluation group (HEPE) at the Nuffield Department of Primary Care, University of Oxford. 

Her expertise lies in the economic evaluations of complex public health interventions, specifically applied to the fields of digital health innovations, mental health, children’s social care and perinatal health. 

Kim has been a Consultant Obstetrician & Gynaecologist in Sunderland since 1994 with clinical interests are high-risk pregnancy, fetal medicine & intrapartum care. He was Director of Research & Innovation for 10 years, and is a Visiting Professor at Sunderland University.

Kim is an active clinical researcher, and co-leads a small but highly-effective team delivering NIHR portfolio trials in both obstetrics & gynaecology. He has had a long-term interest in obstetric skills-drills, human factors, & leadership skills training, & is involved in multidisciplinary teaching across the UK and abroad.

Gordon C. S. Smith is Professor of Obstetrics and Gynaecology, University of Cambridge, and a Consultant in Fetal Medicine at the Rosie Hospital, Cambridge, UK, since 2001. He has MD, PhD & DSc degrees from the University of Glasgow, UK. He held Wellcome Trust research training fellowships at the University of Glasgow and Cornell University, USA. He was elected FMedSci in 2010. His current research is focused on predicting placentally-related complications of human pregnancy and studying the underlying mechanisms of disease. He has ~£10M in current funding as chief investigator (principally Wellcome Trust, Wellcome Leap and MRC).